13F-HR/A filed by BIOS Capital Management, LP
BIOS Capital Management, LP filed this 13F-HR/A for the quarter ended 2024-12-31, filed 2025-02-18, with 6 holding rows worth $94,098,846.
- Accession
- 0001104659-25-014450
- Filer
- CIK 1813845
- Filed
- 2025-02-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, amendment of type restatement, 9 entries on the cover page, a total value of $94,098,846 stated on the cover page (in dollars after the unit check, H1), rows summing to $94,098,846 with VALUE read as dollars as filed, 13F file number 028-24868. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSteelhead Capital Management, LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS INC | 005083100 | COM | 9,893,651 | $78,753,462 | dollars as filed | |
| COGNITION THERAPEUTICS INC | 19243B102 | COM | 6,000,000 | $4,207,800 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 1,690,751 | $3,888,727 | dollars as filed | |
| LANTERN PHARMA INC | 51654W101 | COM | 1,207,709 | $3,852,591 | dollars as filed | |
| IN8BIO INC | 45674E109 | COM | 8,600,001 | $2,211,920 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 995,249 | $1,184,346 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-010964 | superseded | 2025-02-10 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-25-014450 | this filing | 2025-02-18 | acceptance time not in the bulk data set |